Overview

Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori

Status:
NOT_YET_RECRUITING
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of keverprazan with different doses of amoxicillin for Helicobacter Pylori.
Phase:
PHASE4
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Treatments:
Amoxicillin
Anti-Bacterial Agents